NHU(SZ:002001)2014-03-28 16:00Financial Performance - The company's operating revenue for 2013 was CNY 4,237,635,148.40, representing a 16.69% increase compared to CNY 3,631,417,484.17 in 2012[24] - The net profit attributable to shareholders for 2013 was CNY 882,120,714.89, a 3.76% increase from CNY 850,172,805.14 in the previous year[24] - The total profit for 2013 was CNY 1,059.14 million, reflecting a growth of 3.92% compared to the previous year[36] - The company reported a decrease of 4.43% in net profit after deducting non-recurring gains and losses, totaling CNY 855,444,133.61 in 2013[24] - The basic earnings per share for 2013 was CNY 1.22, up 4.27% from CNY 1.17 in 2012[24] - The company reported a main business income of CNY 4,222.99 million, up 16.62% from the previous year[37] Cash Flow and Assets - The net cash flow from operating activities increased by 35.42% to CNY 1,335,018,638.43 from CNY 985,864,876.47 in 2012[24] - The company’s cash and cash equivalents increased by 166.35% to CNY 389.49 million, compared to a decrease in the previous year[50] - Total assets at the end of 2013 were CNY 8,555,874,591.90, reflecting a 9.2% increase from CNY 7,835,075,904.54 at the end of 2012[24] - Current assets rose to CNY 5,062,502,669.09, up from CNY 4,676,712,967.48, indicating an increase of about 8.2%[174] - Cash and cash equivalents increased to CNY 2,664,710,568.85 from CNY 2,368,520,031.34, a growth of approximately 12.5%[174] Investments and R&D - Research and development expenses totaled CNY 190.45 million, an increase of 18.73% compared to CNY 160.41 million in 2012[46] - The company filed 27 patent applications and received 12 patent grants during the year, indicating strong research progress[36] - The company invested a total of ¥26,626.45 million from raised funds during the reporting period, with cumulative investments reaching ¥107,822.08 million[61] Market and Competition - The company highlighted risks related to industry competition and exchange rate fluctuations, advising investors to be cautious[14] - Over 60% of the company's sales revenue comes from international markets, primarily the US and Europe, making it sensitive to exchange rate fluctuations[80] - The company faced risks related to market competition and price volatility in the vitamin market, influenced by global economic conditions[78] Shareholder and Dividend Information - The company plans to distribute a cash dividend of CNY 5.00 per 10 shares, with no bonus shares issued[6] - The company reported a cash dividend payout ratio of 100% for the current profit distribution plan, reflecting its commitment to returning value to shareholders[89] - The largest shareholder, New Hecheng Holdings Group Co., Ltd., holds 409,118,838 shares, representing 56.36% of the total shares[113] Corporate Governance and Management - The company has maintained a stable leadership structure with no changes in the board of directors or senior management during the reporting period[121] - The company has established a transparent performance evaluation and incentive mechanism linking the remuneration of directors and senior management to company performance[140] - The company has a governance structure that ensures independence from its controlling shareholder, with no interference in decision-making[139] Legal and Compliance - There were no significant litigation or arbitration matters during the reporting period, indicating a stable legal environment for the company[97] - The company maintained compliance with the Company Law and relevant regulations, ensuring no discrepancies in governance practices[142] Future Outlook - The company anticipates a recovery in market demand for vitamins and flavor products as the global economy, particularly in Europe and the US, shows signs of growth[77] - The company aims to stabilize its existing business while exploring new business opportunities and potential mergers and acquisitions to accelerate growth[77]